Status: Not yet recruiting
The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31
The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP. Regimen B will evaluate the safety and efficacy of a single study drug, LM11A-31, in participants with PSP.
Participants needed: 147
Trial details
Phase: Phase 2Age: 41-86Biological sex: AllType: InterventionalSponsor: Adam BoxerUpdated: Apr 27, 2026
Eligibility criteria
Clinical diagnosis of possible or probable PSP Richardson's Syndrome as defined... [+6]
Females who are breastfeeding or pregnant (as documented by a urine pregnancy te... [+19]